RecruitingNot ApplicableNCT06566560

The ROAD 2.0 to Sustainable Medication Use: Redispensing Unused Oral Anticancer Drugs

Cost-savings and Environmental Impact Obtained From Redispensing Unused Oral Anticancer Drugs


Sponsor

Radboud University Medical Center

Enrollment

2,500 participants

Start Date

Jan 10, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

The goal of this prospective intervention study is to investigate the effectiveness of redispensing unused oral anticancer drugs. The main questions it aims to answer are: * What are the cost-savings of redispensing unused oral anticancer drugs? * What is the environmental impact of redispensing unused oral anticancer drugs? Researchers will compare redispensing unused oral anticancer drugs to the standard practice of disposal. Participants will receive their oral anticancer drugs in a sealed bag with a temperature indicator if needed. They will be asked to return any unused oral anticancer drugs to the pharmacy during their next visit to the hospital.


Eligibility

Inclusion Criteria2

  • Patients of all ages
  • A clinical diagnosis of cancer using an oral anticancer drug that requires storage at room temperature according to the Summary of Product Characteristics (SmPC).

Exclusion Criteria2

  • Patients that do not understand the Dutch or English language, in written or spoken.
  • Patients receiving prescriptions that contain an amount of tablets that deviates from the regular package size, resulting in the pharmacy dispensing an opened package

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERredispensing oral anticancer drugs

Participants will receive oral anticancer drugs according to their regular prescriptions, distributed in the original manufacturer's package. Following the guideline, some oral anticancer drug (i.e. requiring temperature storage up to 25C degrees) will be supplemented with a validated temperature indicator (Timestrip Neo, customer configuration), enclosed with a seal bag. Patients are requested to return unused oral anticancer drugs to the outpatient pharmacy that distributed them. Pharmacy staff will assess the quality of returned oral anticancer drugs, applying the following criteria: 1. the seal bag is unopened 2. the drug package is unopend and undamaged 3. the expiry date is ≥ 3 months 4. the medication has not been stored outside the product label storage claim Oral anticancer drugs that meet all criteria are restocked, and consecutively redispensed to participants visiting the same outpatient pharmacy.


Locations(1)

Radboudumc

Nijmegen, Gelderland, Netherlands

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06566560


Related Trials